Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives

BACKGROUND/OBJECTIVES: There have been concerns that clozapine treatment may undermine the capacity of the body to fight infection and increase the vulnerability to contracting COVID-19. This review of recent cohort studies investigated (1) whether people with a severe psychiatric disorder are at in...

Descripción completa

Detalles Bibliográficos
Autores principales: Giles, Grace, Varghese, Sunny, Shymko, Gordon, Nguyen, Thinh, Waters, Flavie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620749/
https://www.ncbi.nlm.nih.gov/pubmed/36242537
http://dx.doi.org/10.1093/schbul/sbac148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620749/
https://www.ncbi.nlm.nih.gov/pubmed/36242537
http://dx.doi.org/10.1093/schbul/sbac148

Ejemplares similares